StockData
DexCom Inc logo

DexCom Inc

DXCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 22/3032% below fair value
$80.19−2.33 (-2.82%)

Close on Nov 19, 2026Market cap $29.91BP/E 31.6Yield –

DexCom Share-Based Compensation — Cost of Sales by Quarter

Share-Based Compensation — Cost of Sales ($M)

DexCom Share-Based Compensation — Cost of Sales: $2.70M in Q3 2026, up 170.0% from a year earlier.

Latest, Q3 2026
2.70
Period ended Sep 30, 2026
Change on a year earlier
+170.0%
1 in Q3 2025
History
35 quarters
Since Q4 2017
Sources
32
Documents cited below

Where the Q3 2026 figure comes from

Source: 10-Q (FY2026Q3, filed 2026-10-29) ↗

Reported in Form 10-K & Form 10-Q Footnotes (XBRL).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedShare-Based Compensation — Cost of Sales ($M)Year on yearSource
Q3 2026Sep 30, 20262.70+170.0%10-Q (FY2026Q3, filed 2026-10-29) ↗
Q2 2026Jun 30, 20263.10-22.5%10-Q (FY2026Q2, filed 2026-07-30) ↗
Q1 2026Mar 31, 20262.80-12.5%10-Q (FY2026Q1, filed 2026-04-30) ↗
Q4 2025Dec 31, 20252.70-10.0%10-K (FY2025, filed 2026-02-12) ↗
Q3 2025Sep 30, 20251-72.2%10-Q (FY2026Q3, filed 2026-10-29) ↗
Q2 2025Jun 30, 20254-2.4%10-Q (FY2026Q2, filed 2026-07-30) ↗
Q1 2025Mar 31, 20253.20-13.5%10-Q (FY2026Q1, filed 2026-04-30) ↗
Q4 2024Dec 31, 20243-14.3%10-K (FY2024, filed 2025-02-18) ↗
Q3 2024Sep 30, 20243.60-7.7%10-Q (FY2025Q3, filed 2025-10-30) ↗
Q2 2024Jun 30, 20244.10+5.1%10-Q (FY2025Q2, filed 2025-07-30) ↗
Q1 2024Mar 31, 20243.70+12.1%10-Q (FY2025Q1, filed 2025-05-01) ↗
Q4 2023Dec 31, 20233.50+16.7%10-K (FY2023, filed 2024-02-08) ↗
Q3 2023Sep 30, 20233.90+30.0%10-Q (FY2024Q3, filed 2024-10-24) ↗
Q2 2023Jun 30, 20233.90+39.3%10-Q (FY2024Q2, filed 2024-07-25) ↗
Q1 2023Mar 31, 20233.30+43.5%10-Q (FY2024Q1, filed 2024-04-25) ↗
Q4 2022Dec 31, 20223+57.9%10-K (FY2022, filed 2023-02-09) ↗

Cite this data

StockData. (2026). DexCom Share-Based Compensation — Cost of Sales ($M), quarterly Q4 2017–Q3 2026 [Data set]. Compiled from DexCom SEC filings and investor materials. https://stockdatahq.com/stocks/dxcm/kpis/sbc-alloc-cos

See every metric in the DexCom KPI table. Data updated Nov 7, 2026.

See a number that looks wrong?